Atorvastatin Calcium
Product Images NDC 43353-287

6 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 43353-287). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle Label 40mg (43353 287)

Bottle Label 40mg (43353 287)
Packaging label for Atorvastatin Calcium 40 mg tablets from Aphena Pharma Solutions - Tennessee, LLC. The label indicates a package containing 15 tablets with storage instructions and manufacturer details (Apotex Inc., Toronto, Canada). The product is labeled as Rx only with visible NDC 43353-0287-15.*
FDA Label Image

Aphena Pharma Solutions (TN)

Aphena Pharma Solutions (TN)
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph showing cumulative incidence percentage over a period of 3.5 years comparing Atorvastatin and placebo. The solid line represents Atorvastatin with a lower cumulative incidence compared to the dashed line for placebo. A hazard ratio (HR) of 0.64 (0.50-0.83) with a p-value of 0.0005 is indicated on the graph.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A line graph showing cumulative hazard percentage over time comparing Atorvastatin and placebo groups over four years. The x-axis represents years to first primary endpoint, and the y-axis shows cumulative hazard percentage. Two lines display the data with Atorvastatin having a lower cumulative hazard compared to placebo, with a hazard ratio of 0.63 (0.48-0.83).*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing a cardiovascular event over 5 years for Atorvastatin 10 mg versus Atorvastatin 80 mg. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis depicts the percentage of subjects experiencing the event. The 10 mg group is shown with a dashed line, while the 80 mg group is a solid line, with hazard ratio (HR) and p-value also indicated.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of Atorvastatin Calcium showing the molecular arrangement including phenyl rings, fluorophenyl group, and calcium ions as part of the compound's structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.